Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery

Compare Versions of: "Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery"

The Compare function compares two years of the measure specifications found in the header of the measure's HTML. It does not include a comparison of any information in the body of the HTML, e.g., population criteria, Clinical Quality Language, or value sets.

Strikethrough text highlighted in red indicates information changed from the previous version. Text highlighted in green indicates information updated in the new eCQM version.

Compare 2026 version to

Table Options

Download

Measure Information	2023 Performance Period	2024 Performance Period	2025 Performance Period	2026 Performance Period
Title	Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery	Cataracts: 20 over 40 or Better Visual Acuity within 90 Days Following Cataract Surgery	Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery	Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS eCQM ID	CMS133v11	CMS133v12	CMS133v13	CMS133v14
CBE ID*	0565e	0565e	0565e	0565e
MIPS Quality ID	191	191	191	191
Measure Steward	American Academy of Ophthalmology	American Academy of Ophthalmology	American Academy of Ophthalmology	American Academy of Ophthalmology
Description	Percentage of cataract surgeries for patients aged 18 and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye... within 90 days following the cataract surgery Show more > Percentage of cataract surgeries for patients aged 18 and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following the cataract surgery Show less	Percentage of cataract surgeries for patients aged 18 and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye... within 90 days following the cataract surgery Show more > Percentage of cataract surgeries for patients aged 18 and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following the cataract surgery Show less	Percentage of cataract surgeries for patients aged 18 and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye... within 90 days following the cataract surgery Show more > Percentage of cataract surgeries for patients aged 18 and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following the cataract surgery Show less	Percentage of cataract surgeries for patients aged 18 and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye... within 90 days following the cataract surgery Show more > Percentage of cataract surgeries for patients aged 18 and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following the cataract surgery Show less
Measure Scoring	Proportion measure	Proportion measure	Proportion measure	Proportion measure
Measure Type	Outcome	Outcome	Outcome	Outcome
Stratification	*See CMS133v11.html	None	None	None
Risk Adjustment	*See CMS133v11.html	None	None	None
Rationale	*See CMS133v11.html	In the United States, cataracts affect more than 24 million adults over 40 years (National Eye Institute, 2019). According to the American Academy of Ophthalmology (2021), cataract surgery has a substantial beneficial impact on visual function and on quality of life. 1. Scientific basis... for measuring visual acuity outcomes after cataract surgery The only reason to perform cataract surgery (other than for a limited set of medical indications) is to improve a patient's vision and associated functioning. The use of a 20/40 visual acuity threshold is based on several considerations. First, it is the level for unrestricted operation of a motor vehicle in the US. Second, it has been consistently used by the FDA in its assessment for approval of intraocular lens (IOL) and other vision devices. Third, it is the literature standard to denote success in cataract surgery. Fourth, work by West et al. in the Salisbury Eye Study suggests that 20/40 is a useful threshold for 50th percentile functioning for several vision-related tasks. Most patients achieve excellent visual acuity after cataract surgery (20/40 or better). This outcome is achieved consistently through careful attention through the accurate measurement of axial length and corneal power and the appropriate selection of an IOL power calculation formula. As such, it reflects the care and diligence with which the surgery is assessed, planned and executed. Failure to achieve this after surgery in eyes without comorbid ocular conditions that would impact the success of the surgery would reflect care that should be assessed for opportunities for improvement. The exclusion of patients with other ocular and systemic conditions known to increase the risk of an adverse outcome reflects the findings of the two published prediction rule papers for cataract surgery outcomes, by Mangione et al. (1995) and Steinberg et al. (1994). In both papers, the presence of comorbid glaucoma and macular degeneration negatively impacted the likelihood of successful outcomes of surgery. Further, as noted in the prior indicator, exclusion of eyes with ocular conditions that could impact the success of the surgery would NOT eliminate the large majority of eyes undergoing surgery while also minimizing the potential adverse selection that might otherwise occur relative to those patients with the most complex situations who might benefit the most from having surgery to maximize their remaining vision. 2. Evidence of a gap in care Cataract surgery successfully restores vision in the majority of people who have the procedure. Data from a study of 368,256 cataract surgeries show that corrected visual acuity (CDVA) of 0.5 (20/40) or better was achieved in 94.3% and CDVA of 1.0 (20/20) or better was achieved in 61.3% of cases (Lundstrom, Barry, Henry, Rosen & Stenevi, 2013). Additionally, data from a UK multi-center Cataract National Dataset found a postoperative visual acuity of 6/12 (20/40) or better was achieved for 94.7% of eyes with no co-pathologies and in 79.9% of eyes with one or more co-pathologies (Jaycock et al., 2009). A rate of 85.5-94.7% of patients achieving a 20/40 or better visual acuity in the context of approximately 3 million cataract surgeries in the US annually would mean that between 160,000 to 435,000 individuals would not achieve a 20/40 or better visual acuity which suggests an opportunity for improvement. Show more > In the United States, cataracts affect more than 24 million adults over 40 years (National Eye Institute, 2019). According to the American Academy of Ophthalmology (2021), cataract surgery has a substantial beneficial impact on visual function and on quality of life. 1. Scientific basis for measuring visual acuity outcomes after cataract surgery The only reason to perform cataract surgery (other than for a limited set of medical indications) is to improve a patient's vision and associated functioning. The use of a 20/40 visual acuity threshold is based on several considerations. First, it is the level for unrestricted operation of a motor vehicle in the US. Second, it has been consistently used by the FDA in its assessment for approval of intraocular lens (IOL) and other vision devices. Third, it is the literature standard to denote success in cataract surgery. Fourth, work by West et al. in the Salisbury Eye Study suggests that 20/40 is a useful threshold for 50th percentile functioning for several vision-related tasks. Most patients achieve excellent visual acuity after cataract surgery (20/40 or better). This outcome is achieved consistently through careful attention through the accurate measurement of axial length and corneal power and the appropriate selection of an IOL power calculation formula. As such, it reflects the care and diligence with which the surgery is assessed, planned and executed. Failure to achieve this after surgery in eyes without comorbid ocular conditions that would impact the success of the surgery would reflect care that should be assessed for opportunities for improvement. The exclusion of patients with other ocular and systemic conditions known to increase the risk of an adverse outcome reflects the findings of the two published prediction rule papers for cataract surgery outcomes, by Mangione et al. (1995) and Steinberg et al. (1994). In both papers, the presence of comorbid glaucoma and macular degeneration negatively impacted the likelihood of successful outcomes of surgery. Further, as noted in the prior indicator, exclusion of eyes with ocular conditions that could impact the success of the surgery would NOT eliminate the large majority of eyes undergoing surgery while also minimizing the potential adverse selection that might otherwise occur relative to those patients with the most complex situations who might benefit the most from having surgery to maximize their remaining vision. 2. Evidence of a gap in care Cataract surgery successfully restores vision in the majority of people who have the procedure. Data from a study of 368,256 cataract surgeries show that corrected visual acuity (CDVA) of 0.5 (20/40) or better was achieved in 94.3% and CDVA of 1.0 (20/20) or better was achieved in 61.3% of cases (Lundstrom, Barry, Henry, Rosen & Stenevi, 2013). Additionally, data from a UK multi-center Cataract National Dataset found a postoperative visual acuity of 6/12 (20/40) or better was achieved for 94.7% of eyes with no co-pathologies and in 79.9% of eyes with one or more co-pathologies (Jaycock et al., 2009). A rate of 85.5-94.7% of patients achieving a 20/40 or better visual acuity in the context of approximately 3 million cataract surgeries in the US annually would mean that between 160,000 to 435,000 individuals would not achieve a 20/40 or better visual acuity which suggests an opportunity for improvement. Show less	In the United States, cataracts affect more than 24 million adults over 40 years (National Eye Institute, 2019). According to (Miller et al., 2022), cataract surgery has a substantial beneficial impact on visual function and on quality of life. 1. Scientific basis for measuring visual... acuity outcomes after cataract surgery The only reason to perform cataract surgery (other than for a limited set of medical indications) is to improve a patient's vision and associated functioning. The use of a 20/40 visual acuity threshold is based on several considerations. First, it is the level for unrestricted operation of a motor vehicle in the US. Second, it has been consistently used by the Food and Drug Administration in its assessment for approval of intraocular lens (IOL) and other vision devices. Third, it is the literature standard to denote success in cataract surgery. Fourth, work by West et al. in the Salisbury Eye Study suggests that 20/40 is a useful threshold for 50th percentile functioning for several vision-related tasks. Most patients achieve excellent visual acuity after cataract surgery (20/40 or better). This outcome is achieved consistently through careful attention through the accurate measurement of axial length and corneal power and the appropriate selection of an IOL power calculation formula. As such, it reflects the care and diligence with which the surgery is assessed, planned and executed. Failure to achieve this after surgery in eyes without comorbid ocular conditions that would impact the success of the surgery would reflect care that should be assessed for opportunities for improvement. The exclusion of patients with other ocular and systemic conditions known to increase the risk of an adverse outcome reflects the findings of the two published prediction rule papers for cataract surgery outcomes, by Mangione et al. (1995) and Steinberg et al. (1994). In both papers, the presence of comorbid glaucoma and macular degeneration negatively impacted the likelihood of successful outcomes of surgery. Further, as noted in the prior indicator, exclusion of eyes with ocular conditions that could impact the success of the surgery would NOT eliminate the large majority of eyes undergoing surgery while also minimizing the potential adverse selection that might otherwise occur relative to those patients with the most complex situations who might benefit the most from having surgery to maximize their remaining vision. 2. Evidence of a gap in care Cataract surgery successfully restores vision in the majority of people who have the procedure. Data from a study of 368,256 cataract surgeries show that corrected visual acuity (CDVA) of 0.5 (20/40) or better was achieved in 94.3% and CDVA of 1.0 (20/20) or better was achieved in 61.3% of cases (Lundstrom et al., 2013). Additionally, data from a UK multi-center Cataract National Dataset found a postoperative visual acuity of 6/12 (20/40) or better was achieved for 94.7% of eyes with no co-pathologies and in 79.9% of eyes with one or more co-pathologies (Jaycock et al., 2009). A rate of 85.5-94.7% of patients achieving a 20/40 or better visual acuity in the context of approximately 3 million cataract surgeries in the US annually would mean that between 160,000 to 435,000 individuals would not achieve a 20/40 or better visual acuity which suggests an opportunity for improvement. Show more > In the United States, cataracts affect more than 24 million adults over 40 years (National Eye Institute, 2019). According to (Miller et al., 2022), cataract surgery has a substantial beneficial impact on visual function and on quality of life. 1. Scientific basis for measuring visual acuity outcomes after cataract surgery The only reason to perform cataract surgery (other than for a limited set of medical indications) is to improve a patient's vision and associated functioning. The use of a 20/40 visual acuity threshold is based on several considerations. First, it is the level for unrestricted operation of a motor vehicle in the US. Second, it has been consistently used by the Food and Drug Administration in its assessment for approval of intraocular lens (IOL) and other vision devices. Third, it is the literature standard to denote success in cataract surgery. Fourth, work by West et al. in the Salisbury Eye Study suggests that 20/40 is a useful threshold for 50th percentile functioning for several vision-related tasks. Most patients achieve excellent visual acuity after cataract surgery (20/40 or better). This outcome is achieved consistently through careful attention through the accurate measurement of axial length and corneal power and the appropriate selection of an IOL power calculation formula. As such, it reflects the care and diligence with which the surgery is assessed, planned and executed. Failure to achieve this after surgery in eyes without comorbid ocular conditions that would impact the success of the surgery would reflect care that should be assessed for opportunities for improvement. The exclusion of patients with other ocular and systemic conditions known to increase the risk of an adverse outcome reflects the findings of the two published prediction rule papers for cataract surgery outcomes, by Mangione et al. (1995) and Steinberg et al. (1994). In both papers, the presence of comorbid glaucoma and macular degeneration negatively impacted the likelihood of successful outcomes of surgery. Further, as noted in the prior indicator, exclusion of eyes with ocular conditions that could impact the success of the surgery would NOT eliminate the large majority of eyes undergoing surgery while also minimizing the potential adverse selection that might otherwise occur relative to those patients with the most complex situations who might benefit the most from having surgery to maximize their remaining vision. 2. Evidence of a gap in care Cataract surgery successfully restores vision in the majority of people who have the procedure. Data from a study of 368,256 cataract surgeries show that corrected visual acuity (CDVA) of 0.5 (20/40) or better was achieved in 94.3% and CDVA of 1.0 (20/20) or better was achieved in 61.3% of cases (Lundstrom et al., 2013). Additionally, data from a UK multi-center Cataract National Dataset found a postoperative visual acuity of 6/12 (20/40) or better was achieved for 94.7% of eyes with no co-pathologies and in 79.9% of eyes with one or more co-pathologies (Jaycock et al., 2009). A rate of 85.5-94.7% of patients achieving a 20/40 or better visual acuity in the context of approximately 3 million cataract surgeries in the US annually would mean that between 160,000 to 435,000 individuals would not achieve a 20/40 or better visual acuity which suggests an opportunity for improvement. Show less	In the United States, cataracts affect more than 24 million adults over 40 years (National Eye Institute, 2019). According to (Miller et al., 2022), cataract surgery has a substantial beneficial impact on visual function and on quality of life. 1. Scientific basis for measuring visual... acuity outcomes after cataract surgery The only reason to perform cataract surgery (other than for a limited set of medical indications) is to improve a patient's vision and associated functioning. The use of a 20/40 visual acuity threshold is based on several considerations. First, it is the level for unrestricted operation of a motor vehicle in the US. Second, it has been consistently used by the Food and Drug Administration in its assessment for approval of intraocular lens (IOL) and other vision devices. Third, it is the literature standard to denote success in cataract surgery. Fourth, work by West et al. in the Salisbury Eye Study suggests that 20/40 is a useful threshold for 50th percentile functioning for several vision-related tasks. Most patients achieve excellent visual acuity after cataract surgery (20/40 or better). This outcome is achieved consistently through careful attention through the accurate measurement of axial length and corneal power and the appropriate selection of an IOL power calculation formula. As such, it reflects the care and diligence with which the surgery is assessed, planned and executed. Failure to achieve this after surgery in eyes without comorbid ocular conditions that would impact the success of the surgery would reflect care that should be assessed for opportunities for improvement. The exclusion of patients with other ocular and systemic conditions known to increase the risk of an adverse outcome reflects the findings of the two published prediction rule papers for cataract surgery outcomes, by Mangione et al. (1995) and Steinberg et al. (1994). In both papers, the presence of comorbid glaucoma and macular degeneration negatively impacted the likelihood of successful outcomes of surgery. Further, as noted in the prior indicator, exclusion of eyes with ocular conditions that could impact the success of the surgery would NOT eliminate the large majority of eyes undergoing surgery while also minimizing the potential adverse selection that might otherwise occur relative to those patients with the most complex situations who might benefit the most from having surgery to maximize their remaining vision. 2. Evidence of a gap in care Cataract surgery successfully restores vision in the majority of people who have the procedure. Data from a study of 368,256 cataract surgeries show that corrected visual acuity (CDVA) of 0.5 (20/40) or better was achieved in 94.3% and CDVA of 1.0 (20/20) or better was achieved in 61.3% of cases (Lundstrom et al., 2013). Additionally, data from a UK multi-center Cataract National Dataset found a postoperative visual acuity of 6/12 (20/40) or better was achieved for 94.7% of eyes with no co-pathologies and in 79.9% of eyes with one or more co-pathologies (Jaycock et al., 2009). A rate of 85.5-94.7% of patients achieving a 20/40 or better visual acuity in the context of approximately 3 million cataract surgeries in the US annually would mean that between 160,000 to 435,000 individuals would not achieve a 20/40 or better visual acuity which suggests an opportunity for improvement. Show more > In the United States, cataracts affect more than 24 million adults over 40 years (National Eye Institute, 2019). According to (Miller et al., 2022), cataract surgery has a substantial beneficial impact on visual function and on quality of life. 1. Scientific basis for measuring visual acuity outcomes after cataract surgery The only reason to perform cataract surgery (other than for a limited set of medical indications) is to improve a patient's vision and associated functioning. The use of a 20/40 visual acuity threshold is based on several considerations. First, it is the level for unrestricted operation of a motor vehicle in the US. Second, it has been consistently used by the Food and Drug Administration in its assessment for approval of intraocular lens (IOL) and other vision devices. Third, it is the literature standard to denote success in cataract surgery. Fourth, work by West et al. in the Salisbury Eye Study suggests that 20/40 is a useful threshold for 50th percentile functioning for several vision-related tasks. Most patients achieve excellent visual acuity after cataract surgery (20/40 or better). This outcome is achieved consistently through careful attention through the accurate measurement of axial length and corneal power and the appropriate selection of an IOL power calculation formula. As such, it reflects the care and diligence with which the surgery is assessed, planned and executed. Failure to achieve this after surgery in eyes without comorbid ocular conditions that would impact the success of the surgery would reflect care that should be assessed for opportunities for improvement. The exclusion of patients with other ocular and systemic conditions known to increase the risk of an adverse outcome reflects the findings of the two published prediction rule papers for cataract surgery outcomes, by Mangione et al. (1995) and Steinberg et al. (1994). In both papers, the presence of comorbid glaucoma and macular degeneration negatively impacted the likelihood of successful outcomes of surgery. Further, as noted in the prior indicator, exclusion of eyes with ocular conditions that could impact the success of the surgery would NOT eliminate the large majority of eyes undergoing surgery while also minimizing the potential adverse selection that might otherwise occur relative to those patients with the most complex situations who might benefit the most from having surgery to maximize their remaining vision. 2. Evidence of a gap in care Cataract surgery successfully restores vision in the majority of people who have the procedure. Data from a study of 368,256 cataract surgeries show that corrected visual acuity (CDVA) of 0.5 (20/40) or better was achieved in 94.3% and CDVA of 1.0 (20/20) or better was achieved in 61.3% of cases (Lundstrom et al., 2013). Additionally, data from a UK multi-center Cataract National Dataset found a postoperative visual acuity of 6/12 (20/40) or better was achieved for 94.7% of eyes with no co-pathologies and in 79.9% of eyes with one or more co-pathologies (Jaycock et al., 2009). A rate of 85.5-94.7% of patients achieving a 20/40 or better visual acuity in the context of approximately 3 million cataract surgeries in the US annually would mean that between 160,000 to 435,000 individuals would not achieve a 20/40 or better visual acuity which suggests an opportunity for improvement. Show less
Clinical Recommendation Statement	*See CMS133v11.html	This is an outcome measure. As such, there is no statement in the guideline specific to this measurement topic.	This is an outcome measure. As such, there is no statement in the guideline specific to this measurement topic.	This is an outcome measure. As such, there is no statement in the guideline specific to this measurement topic.
Improvement Notation	Higher score indicates better quality	Higher score indicates better quality	Higher score indicates better quality	Higher score indicates better quality
Definition	*See CMS133v11.html	None	None	None
Guidance	This eCQM is an episode-based measure. An episode for this measure is defined as each cataract surgery during the measurement period, including instances where more than one cataract procedure was performed during the measurement period. Every cataract surgery during the measurement... period should be counted as a measurable denominator event for the measure calculation. Only procedures performed during January 1 - September 30 of the reporting period will be considered for this measure, in order to determine if 20/40 or better visual acuity has been achieved within the 90 days following the cataract procedure. Cataract procedures performed during October 1 - December 31 are excluded from the initial population. The measure, as written, does not specifically require documentation of laterality. Coding limitations in particular clinical terminologies do not currently allow for that level of specificity (ICD-10-CM includes laterality, but SNOMED-CT does not uniformly include this distinction). Therefore, at this time, it is not a requirement of this measure to indicate laterality of the diagnoses, findings or procedures. Available coding to capture the data elements specified in this measure has been provided. It is assumed that the eligible professional or eligible clinician will record laterality in the patient medical record, as quality care and clinical documentation should include laterality. This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure. Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible encounter codes. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. Show more > This eCQM is an episode-based measure. An episode for this measure is defined as each cataract surgery during the measurement period, including instances where more than one cataract procedure was performed during the measurement period. Every cataract surgery during the measurement period should be counted as a measurable denominator event for the measure calculation. Only procedures performed during January 1 - September 30 of the reporting period will be considered for this measure, in order to determine if 20/40 or better visual acuity has been achieved within the 90 days following the cataract procedure. Cataract procedures performed during October 1 - December 31 are excluded from the initial population. The measure, as written, does not specifically require documentation of laterality. Coding limitations in particular clinical terminologies do not currently allow for that level of specificity (ICD-10-CM includes laterality, but SNOMED-CT does not uniformly include this distinction). Therefore, at this time, it is not a requirement of this measure to indicate laterality of the diagnoses, findings or procedures. Available coding to capture the data elements specified in this measure has been provided. It is assumed that the eligible professional or eligible clinician will record laterality in the patient medical record, as quality care and clinical documentation should include laterality. This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure. Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible encounter codes. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. Show less	This eCQM is an episode-based measure. An episode for this measure is defined as each cataract surgery during the measurement period, including instances where more than one cataract procedure was performed during the measurement period. Every cataract surgery during the measurement... period should be counted as a measurable denominator event for the measure calculation. Only procedures performed during January 1 - September 30 of the reporting period will be considered for this measure, in order to determine if 20/40 or better visual acuity has been achieved within the 90 days following the cataract procedure. Cataract procedures performed during October 1 - December 31 are excluded from the initial population. The measure, as written, does not specifically require documentation of laterality. Coding limitations in particular clinical terminologies do not currently allow for that level of specificity (ICD-10-CM includes laterality, but SNOMED-CT does not uniformly include this distinction). Therefore, at this time, it is not a requirement of this measure to indicate laterality of the diagnoses, findings or procedures. Available coding to capture the data elements specified in this measure has been provided. It is assumed that the eligible professional or eligible clinician will record laterality in the patient medical record, as quality care and clinical documentation should include laterality. This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure. Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible encounter codes. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. Show more > This eCQM is an episode-based measure. An episode for this measure is defined as each cataract surgery during the measurement period, including instances where more than one cataract procedure was performed during the measurement period. Every cataract surgery during the measurement period should be counted as a measurable denominator event for the measure calculation. Only procedures performed during January 1 - September 30 of the reporting period will be considered for this measure, in order to determine if 20/40 or better visual acuity has been achieved within the 90 days following the cataract procedure. Cataract procedures performed during October 1 - December 31 are excluded from the initial population. The measure, as written, does not specifically require documentation of laterality. Coding limitations in particular clinical terminologies do not currently allow for that level of specificity (ICD-10-CM includes laterality, but SNOMED-CT does not uniformly include this distinction). Therefore, at this time, it is not a requirement of this measure to indicate laterality of the diagnoses, findings or procedures. Available coding to capture the data elements specified in this measure has been provided. It is assumed that the eligible professional or eligible clinician will record laterality in the patient medical record, as quality care and clinical documentation should include laterality. This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure. Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible encounter codes. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. Show less	This eCQM is an episode-based measure. An episode for this measure is defined as each cataract surgery during the measurement period, including instances where more than one cataract procedure was performed during the measurement period. Every cataract surgery during the measurement... period should be counted as a measurable denominator event for the measure calculation. Only procedures performed during January 1 - September 30 of the measurement period will be considered for this measure, in order to determine if 20/40 or better visual acuity has been achieved within the 90 days following the cataract procedure. Cataract procedures performed during October 1 - December 31 are excluded from the initial population. The measure, as written, does not specifically require documentation of laterality. Coding limitations in particular clinical terminologies do not currently allow for that level of specificity (ICD-10-CM includes laterality, but SNOMED-CT does not uniformly include this distinction). Therefore, at this time, it is not a requirement of this measure to indicate laterality of the diagnoses, findings or procedures. Available coding to capture the data elements specified in this measure has been provided. It is assumed that the eligible clinician will record laterality in the patient medical record, as quality care and clinical documentation should include laterality. This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure. Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible encounter codes. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. Show more > This eCQM is an episode-based measure. An episode for this measure is defined as each cataract surgery during the measurement period, including instances where more than one cataract procedure was performed during the measurement period. Every cataract surgery during the measurement period should be counted as a measurable denominator event for the measure calculation. Only procedures performed during January 1 - September 30 of the measurement period will be considered for this measure, in order to determine if 20/40 or better visual acuity has been achieved within the 90 days following the cataract procedure. Cataract procedures performed during October 1 - December 31 are excluded from the initial population. The measure, as written, does not specifically require documentation of laterality. Coding limitations in particular clinical terminologies do not currently allow for that level of specificity (ICD-10-CM includes laterality, but SNOMED-CT does not uniformly include this distinction). Therefore, at this time, it is not a requirement of this measure to indicate laterality of the diagnoses, findings or procedures. Available coding to capture the data elements specified in this measure has been provided. It is assumed that the eligible clinician will record laterality in the patient medical record, as quality care and clinical documentation should include laterality. This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure. Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible encounter codes. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. Show less	This eCQM is an episode-based measure. An episode for this measure is defined as each cataract surgery during the measurement period, including instances where more than one cataract procedure was performed during the measurement period. Every cataract surgery during the measurement... period should be counted as a measurable denominator event for the measure calculation. Only procedures performed during January 1 - September 30 of the measurement period will be considered for this measure, in order to determine if 20/40 or better visual acuity has been achieved within the 90 days following the cataract procedure. Cataract procedures performed during October 1 - December 31 are excluded from the initial population. The measure, as written, does not specifically require documentation of laterality. Coding limitations in particular clinical terminologies do not currently allow for that level of specificity (ICD-10-CM includes laterality, but SNOMED-CT does not uniformly include this distinction). Therefore, at this time, it is not a requirement of this measure to indicate laterality of the diagnoses, findings or procedures. Available coding to capture the data elements specified in this measure has been provided. It is assumed that the eligible clinician will record laterality in the patient medical record, as quality care and clinical documentation should include laterality. This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure. Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible encounter codes. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. Show more > This eCQM is an episode-based measure. An episode for this measure is defined as each cataract surgery during the measurement period, including instances where more than one cataract procedure was performed during the measurement period. Every cataract surgery during the measurement period should be counted as a measurable denominator event for the measure calculation. Only procedures performed during January 1 - September 30 of the measurement period will be considered for this measure, in order to determine if 20/40 or better visual acuity has been achieved within the 90 days following the cataract procedure. Cataract procedures performed during October 1 - December 31 are excluded from the initial population. The measure, as written, does not specifically require documentation of laterality. Coding limitations in particular clinical terminologies do not currently allow for that level of specificity (ICD-10-CM includes laterality, but SNOMED-CT does not uniformly include this distinction). Therefore, at this time, it is not a requirement of this measure to indicate laterality of the diagnoses, findings or procedures. Available coding to capture the data elements specified in this measure has been provided. It is assumed that the eligible clinician will record laterality in the patient medical record, as quality care and clinical documentation should include laterality. This measure is to be reported by the clinician performing the cataract surgery procedure. Clinicians who provide only preoperative or postoperative management of cataract patients are not eligible for this measure. Telehealth encounters are not eligible for this measure because the measure does not contain telehealth-eligible encounter codes. This version of the eCQM uses QDM version 5.6. Please refer to the QDM page for more information on the QDM. Show less
Initial Population	All cataract surgeries for patients aged 18 years and older who did not meet any exclusion criteria	All cataract surgeries performed between January and September of the measurement period for patients 18 years and older	All cataract surgeries performed between January and September of the measurement period for patients 18 years and older	All cataract surgeries performed between January and September of the measurement period for patients 18 years and older
Denominator	Equals Initial Population	Equals Initial Population	Equals Initial Population	Equals Initial Population
Denominator Exclusions	Cataract surgeries in patients with significant ocular conditions impacting the visual outcome of surgery	Cataract surgeries in patients with significant ocular conditions impacting the visual outcome of surgery	Cataract surgeries in patients with significant ocular conditions impacting the visual outcome of surgery	Cataract surgeries in patients with significant ocular conditions impacting the visual outcome of surgery Significant ocular conditions include: amblyopia, burn confined to eye and adnexa, cataracts econdary to ocular disorders, congenital cataract, mature or hypermature cataract,... posterior polar cataract, central corneal ulcer, certain types of iridocyclitis, choroidal degenerations, choroidal detachment, choroidal hemorrhage and rupture, cloudy cornea, corneal edema, disorders of cornea including corneal opacity, degeneration of macula and posterior pole, degenerative disorders of globe, diabetic macular edema, diabetic retinopathy disorders of optic chiasm, disorders of visual cortex, disseminated chorioretinitis and disseminated retinochoroiditis, focal chorioretinitis and focal retinochoroiditis, glaucoma, hereditary dystrophies (choroidal, corneal, retinal), hypotony of eye, injury to optic nerve and pathways, macular scare of posterior polar, morgagnian cataract, nystagmus and other irregular eye movements, open wound of eyeball, optic atrophy, optic neuritis, pathologic myopia, posterior lenticonus, prior penetrating keratoplasty, purulent endophthalmitis, retinal detachment with retinal defect, retinal vascular occlusion, retrolental fibroplasias, scleritis, separation of retinal layers, traumatic cataract, uveitis, vascular disorders of iris and ciliary body, and visual field defects Show more > Cataract surgeries in patients with significant ocular conditions impacting the visual outcome of surgery Significant ocular conditions include: amblyopia, burn confined to eye and adnexa, cataracts econdary to ocular disorders, congenital cataract, mature or hypermature cataract, posterior polar cataract, central corneal ulcer, certain types of iridocyclitis, choroidal degenerations, choroidal detachment, choroidal hemorrhage and rupture, cloudy cornea, corneal edema, disorders of cornea including corneal opacity, degeneration of macula and posterior pole, degenerative disorders of globe, diabetic macular edema, diabetic retinopathy disorders of optic chiasm, disorders of visual cortex, disseminated chorioretinitis and disseminated retinochoroiditis, focal chorioretinitis and focal retinochoroiditis, glaucoma, hereditary dystrophies (choroidal, corneal, retinal), hypotony of eye, injury to optic nerve and pathways, macular scare of posterior polar, morgagnian cataract, nystagmus and other irregular eye movements, open wound of eyeball, optic atrophy, optic neuritis, pathologic myopia, posterior lenticonus, prior penetrating keratoplasty, purulent endophthalmitis, retinal detachment with retinal defect, retinal vascular occlusion, retrolental fibroplasias, scleritis, separation of retinal layers, traumatic cataract, uveitis, vascular disorders of iris and ciliary body, and visual field defects Show less
Numerator	Cataract surgeries with best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following cataract surgery	Cataract surgeries with best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following cataract surgery	Cataract surgeries with best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following cataract surgery	Cataract surgeries with best-corrected visual acuity of 20/40 or better (distance or near) achieved in the operative eye within 90 days following cataract surgery
Numerator Exclusions	Not Applicable	Not Applicable	Not Applicable	None
Denominator Exceptions	None	None	None	None
Telehealth Eligible	No	No	No	No
Next Version	CMS133v12	CMS133v13	CMS133v14	No Version Available
Previous Version	No Version Available	CMS133v11	CMS133v12	CMS133v13

Download XML

Download CSV

Specifications

Additional Resources for CMS133v14

CMS133-v14.0.000-TRN.xlsx

Header

TRN	Measure Section	Source of Change
Changed the 'eCQM Identifier (Measure Authoring Tool)' field name to 'CMS ID' based on tooling updates.	CMS ID	Standards/Technical Update
Updated the eCQM version number.	eCQM Version Number	Annual Update
Updated the generic measurement period from 'January 1, 20XX through December 31, 20XX' to specify 'January 1, 2026 through December 31, 2026' based on tooling updates.	Measurement Period	Standards/Technical Update
Removed 'PCPI(R) Foundation (PCPI[R])' as a Measure Developer to reflect active Measure Developers.	Measure Developer	Measure Lead
Updated copyright.	Copyright	Annual Update
Updated disclaimer.	Disclaimer	Annual Update
Updated references and measure header to reflect current evidence and new or updated literature.	Reference	Measure Lead
Revised denominator exclusions statement to include examples of significant ocular conditions that meet exclusion criteria.	Denominator Exclusions	Measure Lead
Changed 'Numerator Exclusions' field to read 'None' instead of 'Not Applicable' when no exclusions are present.	Numerator Exclusions	Standards/Technical Update

Logic

TRN	Measure Section	Source of Change
Updated Measure Primary CQL Library Name from 'Cataracts2040BCVAwithin90Days' to 'CMS133Cataracts2040BCVA90DaysQDM' for alignment with the CQL Style Guide.	Definitions	Standards/Technical Update
Updated the version number of the Global Common Functions Library to v9.0.000 and the library name from 'MATGlobalCommonFunctionsQDM' to 'CQMCommonQDM.'	Definitions	Annual Update
Updated the timing comparison precision in the definitions by adding 'day of' operator to align with the measure intent and address time zone differences.	Definitions	Measure Lead
Updated logic to include a definition for 'Cataract Surgeries in Patients with Significant Ocular Conditions Impacting the Visual Outcome of Surgery' to streamline denominator exclusion definition in logic.	Definitions	Measure Lead
Updated the names of CQL definitions, functions, and/or aliases for clarification and to align with the CQL Style Guide.	Definitions	Standards/Technical Update
Updated Measure Primary CQL Library Name from 'Cataracts2040BCVAwithin90Days' to 'CMS133Cataracts2040BCVA90DaysQDM' for alignment with the CQL Style Guide.	Functions	Standards/Technical Update
Updated the version number of the Global Common Functions Library to v9.0.000 and the library name from 'MATGlobalCommonFunctionsQDM' to 'CQMCommonQDM.'	Functions	Annual Update

Value Set

The VSAC is the source of truth for the value set content, please visit the VSAC for downloads of current value sets.

TRN	Measure Section	Source of Change
Value Set 'Acute and Subacute Iridocyclitis' (2.16.840.1.113883.3.526.3.1241): Added 18 SNOMEDCT codes (334821000119108, 340421000119101, 345761000119107, 6395007, 87807004, 1092761000119105, 15678641000119101, 15678681000119106, 15678721000119100, 15678761000119105, 15678801000119102, 15678841000119100, 15991591000119106, 15991631000119106, 15991671000119109, 332731000119108, 338341000119103, 344111000119109) based on SME/expert recommendations. Deleted 2 SNOMEDCT codes (193488003, 267618008) based on code system/terminology updates. Added 9 ICD10CM codes (H16.031, H16.032, H16.033, A18.54, A51.43, A54.32, B00.51, B02.32, D86.83) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Amblyopia' (2.16.840.1.113883.3.526.3.1448): Added 3 SNOMEDCT codes (16697921000119109, 16697961000119104, 16698001000119102) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Burn Confined to Eye and Adnexa' (2.16.840.1.113883.3.526.3.1409): Added 24 SNOMEDCT codes (12081651000119107, 12081691000119102, 12081491000119100, 12081531000119100, 770555009, 473243005, 473244004, 473248001, 473246002, 473250009, 473245003, 473249009, 40901000087106, 12081931000119106, 41171000087107, 12081971000119109, 12081251000119109, 12081411000119109, 12114081000119101, 12081291000119104, 12081451000119105, 12115361000119108, 232029005, 232027007) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Cataract Congenital' (2.16.840.1.113883.3.526.3.1412): Added 2 SNOMEDCT codes (348771000119108, 348321000119108) based on code system/terminology updates. Added 7 SNOMEDCT codes (341461000119103, 335851000119101, 346701000119104, 342821000119103, 346691000119104, 341441000119102, 335831000119107) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Cataract Mature or Hypermature' (2.16.840.1.113883.3.526.3.1413): Added 15 ICD10CM codes (H25.011, H25.012, H25.013, H25.091, H25.092, H25.093, H25.099, H25.11, H25.12, H25.13, H25.811, H25.812, H25.813, H25.89, H25.9) based on SME/expert recommendations. Deleted 1 SNOMEDCT code (264443002) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Cataract Posterior Polar' (2.16.840.1.113883.3.526.3.1414): Deleted 3 SNOMEDCT codes (15737881000119104, 15737921000119106, 15737961000119101) based on code system/terminology updates. Deleted 2 SNOMEDCT codes (15737681000119103, 6477021000119103) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Cataract Secondary to Ocular Disorders' (2.16.840.1.113883.3.526.3.1410): Added 7 SNOMEDCT codes (15990151000119103, 15990191000119108, 15990231000119104, 1217661001, 343351000119105, 337561000119109, 331941000119109) based on SME/expert recommendations. Deleted 1 SNOMEDCT code (76309006) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Cataract Surgery' (2.16.840.1.113883.3.526.3.1411): Added 7 SNOMEDCT codes (38631000087106, 38621000087109, 3700004, 1231299001, 1231300009, 1231296008, 1236928007) based on SME/expert recommendations. Added 4 CPT codes (66987, 66988, 66989, 66991) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Central Corneal Ulcer' (2.16.840.1.113883.3.526.3.1428): Added 2 SNOMEDCT codes (347031000119107, 397571007) based on SME/expert recommendations. Deleted 1 SNOMEDCT code (397567009) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Certain Types of Iridocyclitis' (2.16.840.1.113883.3.526.3.1415): Added 18 SNOMEDCT codes (335061000119105, 340671000119102, 680291000119102, 1092761000119105, 15678721000119100, 15678841000119100, 15679361000119103, 15679401000119107, 15679441000119109, 15991591000119106, 15991631000119106, 15991671000119109, 332731000119108, 332921000119107, 338341000119103, 338531000119102, 344111000119109, 344301000119109) based on SME/expert recommendations. Deleted 3 SNOMEDCT codes (29538005, 267619000, 193488003) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Choroidal Degenerations' (2.16.840.1.113883.3.526.3.1450): Added 11 ICD10CM codes (H31.111, H31.112, H31.113, H31.121, H31.122, H31.123, H31.23, H31.20, H31.22, H31.29, H31.21) based on SME/expert recommendations. Added 17 SNOMEDCT codes (15989911000119106, 15989951000119107, 15989991000119102, 247149008, 336081000119106, 341691000119108, 346911000119103, 335401000119103, 336491000119103, 341011000119108, 342101000119104, 346281000119104, 347261000119106, 1231678007, 193468002, 312918002, 15989831000119105) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Choroidal Detachment' (2.16.840.1.113883.3.526.3.1451): Deleted 7 SNOMEDCT codes (341671000119107, 336061000119102, 341661000119101, 336051000119104, 339481000119109, 333881000119109, 344611000119101) based on SME/expert recommendations. Added 1 SNOMEDCT code (346901000119101) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Choroidal Hemorrhage and Rupture' (2.16.840.1.113883.3.526.3.1452): Added 3 SNOMEDCT codes (335201000119104, 340811000119106, 346891000119100) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Chronic Iridocyclitis' (2.16.840.1.113883.3.526.3.1416): Added 3 ICD10CM codes (H20.023, H20.022, H20.021) based on SME/expert recommendations. Added 3 SNOMEDCT codes (344111000119109, 338341000119103, 332731000119108) based on code system/terminology changes.	Terminology	Annual Update
Value Set 'Degeneration of Macula and Posterior Pole' (2.16.840.1.113883.3.526.3.1453): Added 45 SNOMEDCT codes (15628811000119100, 15628851000119104, 15628771000119100, 15628611000119101, 15628531000119107, 15628571000119105, 770097006, 15639131000119107, 15639181000119108, 15639231000119102, 331821000119106, 337441000119109, 343231000119106, 16320791000119106, 16320831000119100, 16320871000119102, 1285513008, 1231253003, 677851000119101, 677901000119105, 677951000119109, 677961000119106, 677971000119100, 677911000119108, 677921000119101, 677861000119104, 677871000119105, 769244003, 769245002, 860721006, 725590001, 1187639002, 1285507004, 1285540008, 1285589003, 232014008, 15631531000119100, 15631611000119106, 1296526000, 677881000119108, 677931000119103, 677981000119102, 774010000, 1338026004, 1338027008) based on SME/expert recommendations. Deleted 2 SNOMEDCT codes (371098002, 15631571000119102) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Degenerative Disorders of Globe' (2.16.840.1.113883.3.526.3.1454): Added 81 SNOMEDCT codes (333591000119109, 339201000119102, 344951000119107, 332441000119107, 338051000119103, 343821000119109, 1208895006, 1296526000, 15633051000119102, 15633091000119107, 1208890001, 335531000119109, 341141000119106, 346401000119108, 737271000, 24210004, 15632971000119103, 15632931000119101, 15633011000119103, 314010006, 15732881000119102, 15732921000119109, 15732961000119104, 343841000119103, 36524008, 1285555004, 347251000119109, 15628651000119100, 15628691000119105, 15628731000119103, 15733361000119105, 15733401000119101, 232065000, 232076001, 331381000119100, 336991000119108, 343101000119108, 348071000119106, 348521000119104, 349111000119108, 332481000119102, 338091000119108, 343861000119104, 15735721000119100, 15735801000119102, 231927007, 246937001, 27971006, 333241000119103, 333661000119101, 338851000119105, 345021000119104, 419051009, 419648001, 450921000124103, 679171000119109, 679181000119107, 679191000119105, 679201000119108, 679211000119106, 679221000119104, 679231000119101, 679241000119105, 679251000119107, 72620002, 88538005, 89182000, 231929005, 28143002, 231944006, 1285507004, 16419701000119108, 16419741000119105, 16419781000119100, 424358006, 770791000, 83231000119101, 193508003, 335881000119108, 341491000119105, 346741000119102) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Diabetic Macular Edema' (2.16.840.1.113883.3.526.3.1455): Added 11 SNOMEDCT codes (399877009, 769217008, 769218003, 769221001, 769222008, 770097006, 870421009, 870529009, 871778008, 871781003, 97331000119101) based on SME/expert recommendations. Deleted 45 ICD10CM codes (E08.3531, E08.3532, E08.3533, E08.3541, E08.3542, E08.3543, E08.3551, E08.3552, E08.3553, E09.3531, E09.3532, E09.3533, E09.3541, E09.3542, E09.3543, E09.3551, E09.3552, E09.3553, E10.3531, E10.3532, E10.3533, E10.3541, E10.3542, E10.3543, E10.3551, E10.3552, E10.3553, E11.3531, E11.3532, E11.3533, E11.3541, E11.3542, E11.3543, E11.3551, E11.3552, E11.3553, E13.3531, E13.3532, E13.3533, E13.3541, E13.3542, E13.3543, E13.3551, E13.3552, E13.3553) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Diabetic Retinopathy' (2.16.840.1.113883.3.526.3.327): Added 2 SNOMEDCT codes (1306699009, 1306700005) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Disorders of Cornea Including Corneal Opacity' (2.16.840.1.113883.3.526.3.1419): Added 19 SNOMEDCT codes (1217688006, 704272003, 675331000119106, 675341000119102, 675351000119100, 341831000119108, 336221000119104, 246967007, 840489001, 15987391000119105, 15987431000119100, 339481000119109, 333881000119109, 1231682009, 344611000119101, 338841000119108, 333231000119107, 1003921006, 1144352007) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Disorders of Optic Chiasm' (2.16.840.1.113883.3.526.3.1457): Deleted 1 SNOMEDCT code (69820004) based on SME/expert recommendations.	Terminology	Annual Update
Value Set ‘Disorders of Visual Cortex’ (2.16.840.1.113883.3.526.3.1458): Added 5 SNOMEDCT codes (15913031000119100, 1172900005, 773548008, 413924001, 39194005) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Focal Chorioretinitis and Focal Retinochoroiditis' (2.16.840.1.113883.3.526.3.1460): Added 9 SNOMEDCT codes (333011000119108, 333201000119100, 334641000119103, 338621000119101, 338811000119109, 340241000119106, 344391000119103, 344581000119108, 345601000119100) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Glaucoma' (2.16.840.1.113883.3.526.3.1423): Added 114 SNOMEDCT codes (1304240002, 1306287007, 1306288002, 1303340008, 1303338003, 1303339006, 1331895002, 1331893009, 1331894003, 1303455003, 1303454004, 1303456002, 1306782000, 1306789009, 1306787006, 1303890000, 1303889009, 1303891001, 1285335004, 193555008, 1111391000000107, 1111401000000105, 1304034000, 1304035004, 1304036003, 1285332001, 1285710008, 1285712000, 1285711007, 1285713005, 1285716002, 1285717006, 1285718001, 1303462007, 1303463002, 1303464008, 1303701001, 1303704009, 1303706006, 1303702008, 1303707002, 1303708007, 1303892008, 1303893003, 1303894009, 1303927008, 1303928003, 1303929006, 1304027002, 1304029004, 1304030009, 1304031008, 1304032001, 1304033006, 392029006, 1304266004, 1304267008, 1304268003, 1304282003, 1304284002, 1304285001, 1306289005, 1306298008, 1306301007, 1306328002, 1306329005, 1306330000, 1306331001, 1306332008, 1306333003, 1306607000, 1306746005, 1306749003, 1306750003, 1306768000, 1306772001, 1306773006, 1306774000, 1306777007, 1306778002, 1306868005, 1306869002, 1306873004, 1306874005, 1306875006, 1306876007, 1306877003, 1306878008, 1306879000, 1306884006, 1306885007, 1306886008, 1332297002, 1332298007, 1332299004, 1335974003, 1335975002, 1335980006, 1335982003, 1335985001, 1336007002, 1336008007, 1336009004, 1336022007, 1336023002, 1336024008, 1336042003, 15738961000119102, 15739001000119109, 15995591000119109, 15995631000119109, 344531000119107, 333151000119108, 338761000119103) based on code system/terminology updates. Deleted 20 SNOMEDCT codes (12239421000119101, 15633321000119108, 15640441000119104, 15736441000119108, 15736481000119103, 15736521000119103, 15736561000119108, 15736601000119108, 15736641000119105, 15739201000119104, 15739241000119102, 15739281000119107, 15739321000119102, 15739361000119107, 15739401000119103, 15739681000119109, 15739721000119103, 15739761000119108, 232090003, 53667005) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes' (2.16.840.1.113883.3.526.3.1461): Added 54 SNOMEDCT codes (1331895002, 1331894003, 1331893009, 1306782000, 1306789009, 1306787006, 1303890000, 1303889009, 1303891001, 1303454004, 1303464008, 1303463002, 1303455003, 1303456002, 1303462007, 193562004, 333111000119107, 344491000119107, 338721000119108, 1304267008, 1304266004, 1304268003, 15739641000119104, 1003657004, 15673001000119103, 204113001, 415176004, 897585008, 1003428009, 15738961000119102, 15739001000119109, 890423003, 344531000119107, 1285643003, 1306772001, 1306773006, 1306774000, 1306778002, 1306768000, 860798008, 716166002, 713457002, 331471000119105, 337081000119109, 1306607000, 1306868005, 1306869002, 1003425007, 1111401000000105, 1304034000, 1304035004, 1304036003, 1231270006, 1231271005) based on SME/expert recommendations. Deleted 9 SNOMEDCT codes (15736561000119108, 15736601000119108, 15736641000119105, 15739321000119102, 15739361000119107, 15739401000119103, 15739681000119109, 15739721000119103, 15739761000119108) based on code system/terminology updates. Deleted 4 SNOMEDCT codes (68341007, 15739441000119101, 15739481000119106, 29538005) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Hereditary Choroidal Dystrophies' (2.16.840.1.113883.3.526.3.1462): Added 3 SNOMEDCT codes (15989831000119105, 1231678007, 193468002) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Hereditary Corneal Dystrophies' (2.16.840.1.113883.3.526.3.1424): Added 4 SNOMEDCT codes (680491000119103, 680501000119105, 680511000119108, 702359002) based on SME/expert recommendations. Deleted 1 SNOMEDCT code (416633008) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Hereditary Retinal Dystrophies' (2.16.840.1.113883.3.526.3.1463): Added 15 SNOMEDCT codes (698847000, 698848005, 514793471000119104, 1010610007, 1172605003, 1220597000, 15699201000119104, 15699241000119102, 15699281000119107, 232054005, 232055006, 237611007, 237984008, 719282008, 723452007) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Hypotony of Eye' (2.16.840.1.113883.3.526.3.1426): Added 3 SNOMEDCT codes (677291000119105, 677301000119106, 677311000119109) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Injury to Optic Nerve and Pathways' (2.16.840.1.113883.3.526.3.1427): Added 5 SNOMEDCT codes (1339033009, 735646005, 762357005, 762358000, 735648006) based on SME/expert recommendations. Deleted 1 SNOMEDCT code (230514006) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Macular Scar of Posterior Polar' (2.16.840.1.113883.3.526.3.1559): Added 4 SNOMEDCT codes (1137552000, 1137554004, 1137553005, 30537002) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Nystagmus and Other Irregular Eye Movements' (2.16.840.1.113883.3.526.3.1465): Added 21 SNOMEDCT codes (1208860008, 1217642000, 1217639006, 1217636004, 1217662008, 1220537002, 95791002, 95793004, 95789005, 95792009, 783562005, 1010461005, 1010460006, 194360001, 246759006, 285764004, 246758003, 278467003, 267664003, 246764005, 278465006) based on SME/expert recommendations.	Terminology	Annual Update
Replaced Value Set 'ONC Administrative Sex' (2.16.840.1.113762.1.4.1) with Value Set 'Federal Administrative Sex' (2.16.840.1.113762.1.4.1021.121) to represent Supplemental Data Element 'SDE Sex' based on revised standards.	Terminology	Standards/Technical Update
Value Set 'Open Wound of Eyeball' (2.16.840.1.113883.3.526.3.1430): Added 2 SNOMEDCT codes (42241000087103, 346301000119100) based on code system/terminology updates. Deleted 1 SNOMEDCT code (12403101000119108) based on code system/terminology updates. Added 3 ICD10CM codes (H31.321, H31.322, H31.323) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Optic Atrophy' (2.16.840.1.113883.3.526.3.1466): Added 3 SNOMEDCT codes (334941000119106, 340551000119105, 345861000119103) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis' (2.16.840.1.113883.3.526.3.1468): Added 2 SNOMEDCT codes (711616006, 345971000119104) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Other Background Retinopathy and Retinal Vascular Changes' (2.16.840.1.113883.3.526.3.1469): Added 3 SNOMEDCT codes (343801000119100, 338031000119109, 332421000119101) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Other Disorders of Optic Nerve' (2.16.840.1.113883.3.526.3.1471): Added 4 SNOMEDCT codes (16376191000119109, 16376241000119109, 16376391000119106, 1231226002) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Other Endophthalmitis' (2.16.840.1.113883.3.526.3.1473): Added 14 SNOMEDCT codes (1231680001, 733337008, 789116000, 1176990003, 1177028005, 870329005, 870330000, 870331001, 870333003, 870335005, 870332008, 333581000119106, 339191000119100, 344941000119105) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Other Proliferative Retinopathy' (2.16.840.1.113883.3.526.3.1480): Added 6 SNOMEDCT codes (332351000119103, 332361000119101, 337961000119104, 337971000119105, 343741000119109, 343731000119100) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Pathologic Myopia' (2.16.840.1.113883.3.526.3.1432): Added 19 SNOMEDCT codes (16837401000119105, 57190000, 333701000119108, 339301000119109, 345061000119109, 232133000, 408757002, 718718009, 733087007, 846622008, 341081000119102, 346341000119103, 232134006, 15628771000119100, 15628811000119100, 15628851000119104, 16320831000119100, 16320871000119102, 773771008) based on SME/expert recommendations. Deleted 2 SNOMEDCT codes (62585004, 346481000119100) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Posterior Lenticonus' (2.16.840.1.113883.3.526.3.1433): Added 3 SNOMEDCT codes (1230066003, 4465002, 897576008) based on code/system terminology updates.	Terminology	Annual Update
Value Set 'Purulent Endophthalmitis' (2.16.840.1.113883.3.526.3.1477): Added 19 SNOMEDCT codes (1099241000119105, 1208910001, 1231646004, 15678401000119100, 1217670003, 1231279007, 1231258007, 1231260009, 1231280005, 15681561000119104, 15681721000119101, 15681681000119107, 1231276000, 711644007, 860836003, 1285506008, 1231700006, 332761000119100, 338371000119105) based on SME/expert recommendations. Deleted 1 SNOMEDCT code (1833005) based on code system/terminology updates.	Terminology	Annual Update
Value Set 'Retinal Detachment with Retinal Defect' (2.16.840.1.113883.3.526.3.1478): Added 20 SNOMEDCT codes (1279847002, 1279846006, 773727009, 1231650006, 232012007, 1231728000, 1231625008, 82571000119107, 82541000119100, 331811000119104, 337431000119100, 343221000119108, 712508005, 332521000119102, 338131000119105, 712506009, 1231698002, 232068003, 232069006, 712507000) based on SME/expert recommendations. Deleted 10 SNOMEDCT codes (193326001, 314494006, 193323009, 193327005, 42059000, 337451000119106, 193324003, 193325002, 15734081000119100, 331831000119109) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Retinal Vascular Occlusion' (2.16.840.1.113883.3.526.3.1479): Added 10 SNOMEDCT codes (344661000119103, 15997991000119107, 232036006, 347011000119102, 786050007, 786049007, 786054003, 786055002, 331801000119102, 733325006) based on SME/expert recommendations. Deleted 2 SNOMEDCT codes (232042005, 232045007) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Retrolental Fibroplasias' (2.16.840.1.113883.3.526.3.1438): Added 6 SNOMEDCT codes (332361000119101, 337971000119105, 343741000119109, 332351000119103, 337961000119104, 343731000119100) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Scleritis' (2.16.840.1.113762.1.4.1226.1): Added 25 SNOMEDCT codes (332281000119101, 337891000119104, 1335863008, 1335866000, 332261000119105, 337871000119100, 343641000119104, 63454000, 36391000119107, 342001000119103, 347181000119109, 1087131000119102, 16000831000119106, 16000791000119100, 16000751000119105, 332241000119106, 337851000119109, 343621000119105, 95797003, 332231000119102, 337841000119107, 343611000119103, 332221000119100, 337831000119103, 343601000119101) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Separation of Retinal Layers' (2.16.840.1.113883.3.526.3.1482): Added 42 SNOMEDCT codes (1255639008, 1279846006, 1279847002, 712507000, 335021000119100, 340631000119100, 345941000119106, 15734081000119102, 15734161000119105, 15734121000119100, 15734321000119103, 15734401000119104, 1231728000, 1306765002, 1306766001, 1306767005, 31181000119100, 15734521000119107, 15734361000119108, 15734561000119102, 31191000119102, 15734681000119105, 15734641000119100, 314494006, 331111000119108, 331831000119109, 337451000119106, 1231625008, 331811000119104, 337431000119100, 44268007, 713345005, 15733681000119107, 15733601000119104, 193329008, 332341000119100, 337951000119101, 361130009, 723023003, 83405000, 86923008, 95493003) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Traumatic Cataract' (2.16.840.1.113883.3.526.3.1443): Added 3 SNOMEDCT codes (331781000119101, 337401000119107, 343191000119102) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Uveitis' (2.16.840.1.113883.3.526.3.1444): Added 57 SNOMEDCT codes (1231259004, 370506009, 722607009, 1269223003, 15630771000119104, 15630811000119104, 15630851000119103, 314030005, 314493000, 415657000, 86219005, 95680001, 1156843000, 1156844006, 1156845007, 1156846008, 336041000119101, 341651000119103, 346871000119101, 335971000119100, 341581000119106, 346801000119106, 1217647006, 1144978007, 1177018001, 1197180007, 267619000, 786077003, 186266008, 15678601000119103, 15678521000119108, 15678561000119103, 1208838005, 1216988003, 1177029002, 434391000124109, 1163460006, 1177031006, 1231232007, 1231665007, 788963006, 333401000119104, 339011000119105, 333391000119101, 339001000119107, 344751000119109, 1231680001, 410481000, 414784001, 733337008, 789116000, 1176981005, 1176982003, 1231676006, 773991005, 789008006, 1231640005) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Vascular Disorders of Iris and Ciliary Body' (2.16.840.1.113883.3.526.3.1445): Added 2 SNOMEDCT codes (82551000119103, 82581000119105) based on SME/expert recommendations.	Terminology	Annual Update
Value Set 'Visual Field Defects' (2.16.840.1.113883.3.526.3.1446): Added 26 SNOMEDCT codes (16059111000119107, 333381000119104, 338991000119107, 344741000119107, 15747361000119104, 15747321000119109, 15747401000119108, 733338003, 336151000119100, 341761000119109, 346971000119106, 16058991000119105, 16058951000119100, 16058911000119101, 678721000119102, 678711000119109, 678701000119106, 332131000119107, 337741000119101, 343511000119104, 336371000119106, 341981000119103, 347161000119100, 333371000119102, 338981000119109, 344731000119103) based on SME/expert recommendations.	Terminology	Annual Update